Investor Presentation February 2020
Conference call July 25 2019 – Inhibiting NOX enzymes to treat multiple diseases with high medical need
Genkyotex conference call on July 25, 2019 at 2 pm CEST
Genkyotex invitation to Biotech Agora in Paris on July 10, 2019
Phase 2 trial of GKT831 in patients with primary biliary cholangitis Top line final results
ILC2019 Presentation – GKT831 Phase 2 in PBC
Management presentation on positive interim Phase 2 results in PBC
Ask us your questions
Suscribe to Newsletter
